Retrieve available abstracts of 32 articles: HTML format
Single Articles
July 2025
WANG J, Wang L, Wang T, Tang T, et al Eye-sparing treatment for sinonasal tumors invading the orbit in the era of
personalized therapy.
Int J Cancer. 2025;157:151-160. PubMedAbstract available
June 2025
SONG XY, Lin L, Yang Y, Hu HH, et al Radiotherapy as an organ-preserving alternative to surgery in patients with
locally advanced esophageal squamous cell carcinoma achieving major pathologic
response after induction immunochemotherapy.
Int J Cancer. 2025 Jun 25. doi: 10.1002/ijc.35515. PubMedAbstract available
MODESTO A, Gibert S, Delmas C, Tougeron D, et al Sizing and concentration analysis of cfDNA using Biabooster technology: Results
from a prospective plasma-based collection of 77 patients with locally advanced
unresectable esophageal cancer.
Int J Cancer. 2025 Jun 20. doi: 10.1002/ijc.70011. PubMedAbstract available
May 2025
LIN H, Ma J, Heng Y, Zhu X, et al CD8(+) T cells in patients with hypopharyngeal squamous cell carcinoma are
susceptible to radiation-induced damage.
Int J Cancer. 2025;156:2010-2023. PubMedAbstract available
YAN L, Lin Y, Lin W, Hong J, et al Treatment outcomes in nasopharyngeal carcinoma patients with parotid lymph node
metastasis: An 11-year experience at a tertiary cancer center.
Int J Cancer. 2025 May 7. doi: 10.1002/ijc.35470. PubMedAbstract available
March 2025
LAN K, Liu S, Li S, Sun X, et al Comparing outcomes and toxicities among patients with nasopharyngeal carcinoma
treated with daytime versus evening radiotherapy: A retrospective analysis with
propensity score matching.
Int J Cancer. 2025 Mar 29. doi: 10.1002/ijc.35408. PubMedAbstract available
Correction to "Chronotherapy in head and neck cancer: A systematic review and
meta-analysis".
Int J Cancer. 2025 Mar 7. doi: 10.1002/ijc.35396. PubMed
February 2025
HU Y, Lu T, Zhang H, Chen B, et al Efficacy and optimal duration of maintenance immunotherapy following systemic
chemoimmunotherapy and locoregional radiotherapy in de novo metastatic
nasopharyngeal carcinoma: A multicenter retrospective cohort study.
Int J Cancer. 2025 Feb 24. doi: 10.1002/ijc.35382. PubMedAbstract available
WANG H, Fan T, Lu Y, Que L, et al Baseline audiometric assessment of newly diagnosed nasopharyngeal carcinoma
patients: a multicentre cross-sectional study.
Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35358. PubMedAbstract available
January 2025
XIAO Z, Chen W, Du Y, Zeng F, et al Efficacy and safety of Anlotinib in combination with gemcitabine and cisplatin as
a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A
single-arm clinical trial.
Int J Cancer. 2025 Jan 18. doi: 10.1002/ijc.35340. PubMedAbstract available
December 2024
WANG J, Li B, Zhang Y, Luo X, et al Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective
chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced
thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2
trial.
Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35261. PubMedAbstract available
JHAWAR SR, Haring C, Pan X, Ma J, et al Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes
in HPV-associated oropharyngeal cancer.
Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35291. PubMedAbstract available
November 2024
JIN ZY, Liu K, Wallar G, Zhou JY, et al Environmental tobacco smoking (ETS) and esophageal cancer: A population-based
case-control study in Jiangsu Province, China.
Int J Cancer. 2024 Nov 18. doi: 10.1002/ijc.35254. PubMedAbstract available
ABUSAMAK M, Abu-Samak AA, Cai W, Al-Waeli H, et al Chronotherapy in head and neck cancer: A systematic review and meta-analysis.
Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35234. PubMedAbstract available
RUTKOWSKI TW, Kurczyk A, Drosik-Rutowicz K, Kiprian D, et al Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the
head and neck: Results of Polish multicenter observational study.
Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35248. PubMedAbstract available
October 2024
RETRACTION: A Multiplicity of Anti-Invasive Effects of Farnesyl Transferase
Inhibitor SCH66336 in Human Head and Neck Cancer.
Int J Cancer. 2024 Oct 22. doi: 10.1002/ijc.35230. PubMedAbstract available
HSU WL, Tao J, Fu S, Yu KJ, et al Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex families.
Int J Cancer. 2024;155:1400-1408. PubMedAbstract available
September 2024
WANG W, Ye L, Li H, Chen W, et al A narrative review on advances in neoadjuvant immunotherapy for esophageal
cancer: Molecular biomarkers and future directions.
Int J Cancer. 2024 Sep 14. doi: 10.1002/ijc.35153. PubMedAbstract available
PIRES C, Marques IJ, Saramago A, Moura MM, et al Identification of novel candidate predisposing genes in familial nonmedullary
thyroid carcinoma implicating DNA damage repair pathways.
Int J Cancer. 2024 Sep 9. doi: 10.1002/ijc.35159. PubMedAbstract available
August 2024
JANKE F, Stritzke F, Dvornikovich K, Franke H, et al Early circulating tumor DNA changes predict outcomes in head and neck cancer
patients under re-radiotherapy.
Int J Cancer. 2024 Aug 30. doi: 10.1002/ijc.35152. PubMedAbstract available
SHI X, Lu M, Li X, Li J, et al The transcriptional landscape and clinico-biological characterization of human
endogenous retroviruses in esophageal squamous cell carcinoma.
Int J Cancer. 2024 Aug 27. doi: 10.1002/ijc.35147. PubMedAbstract available
HUANG H, Zhao Y, Deng Y, Zhan Z, et al Optimal therapeutic strategies for hepatic metachronous oligometastatic
nasopharyngeal carcinoma: Insights from a retrospective study.
Int J Cancer. 2024 Aug 26. doi: 10.1002/ijc.35139. PubMedAbstract available
July 2024
WENG Z, Mai Z, Yuan J, Liu Q, et al Evolution of genome and immunogenome in esophageal squamous cell carcinomas
driven by neoadjuvant chemoradiotherapy.
Int J Cancer. 2024 Jul 31. doi: 10.1002/ijc.35118. PubMedAbstract available
LAURITZEN BB, Gronlund MW, Jakobsen KK, Justesen MM, et al Epidemiological trends and survival of oropharyngeal cancer in a high
HPV-prevalent area: A Danish population-based study from 2000 to 2020.
Int J Cancer. 2024 Jul 17. doi: 10.1002/ijc.35099. PubMedAbstract available
June 2024
MA L, Wang TM, He YQ, Liao Y, et al Multiplex assays reveal anti-EBV antibody profile and its implication in
detection and diagnosis of nasopharyngeal carcinoma.
Int J Cancer. 2024 Jun 18. doi: 10.1002/ijc.35061. PubMedAbstract available
SUN X, Lin X, Yao J, Tian T, et al Potential causal links of long-term exposure to PM(2.5) and its chemical
components with the risk of nasopharyngeal carcinoma recurrence: A 10-year cohort
study in South China.
Int J Cancer. 2024 Jun 11. doi: 10.1002/ijc.35047. PubMedAbstract available
May 2024
GUO D, Jin J, Li D, He Y, et al Analysis of the incidence and mortality trends of esophageal cancer in cancer
registry areas of China and Japan.
Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35003. PubMedAbstract available
April 2024
VASILIADOU I, Grose D, Wilson C, Thapa A, et al The use of pembrolizumab monotherapy for the management of head and neck squamous
cell carcinoma (HNSCC) in the UK.
Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34963. PubMedAbstract available
BUDUKH A, Dora T, Sancheti S, Singh V, et al Outcome of early detection approach in control of breast, cervical, and oral
cancer: Experience from a rural cancer center in India.
Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966. PubMedAbstract available
DI W, Yu J, Zong D, Ge Y, et al Effects of ambient temperature, relative humidity and absolute humidity on risk
of nasopharyngeal carcinoma in China.
Int J Cancer. 2024 Apr 10. doi: 10.1002/ijc.34933. PubMedAbstract available
SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al Antibodies against high-risk human papillomavirus proteins as markers for
noncervical HPV-related cancers in a Black South African population, according to
HIV status.
Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919. PubMedAbstract available
March 2024
CHARTERS E, Cheng K, Dunn M, Heng C, et al Restorabite: Phase II trial of jaw stretching exercises using a novel device for
patients with trismus following head and neck cancer.
Int J Cancer. 2024 Mar 31. doi: 10.1002/ijc.34941. PubMedAbstract available